MaxCyte STX

MaxCyte STX®

 

The MaxCyte STX® Scalable Transfection System uses Flow Electroporation Technology for rapid, high-performance engineering of cells for a broad array of applications. It addresses the R&D arena from early-stage development through pre-clinical work, including toxicology studies. Use the MaxCyte STX to improve the quality and time-to-market of your vaccines, small molecule drugs and biotherapeutics candidates.

 

High-Performance

  • Cell viabilities >90% for commonly used cell types
  • Transfection efficiencies >90%
  • Computer-controlled system for day-to-day and user-to-user consistency

 

Flexible

  • Engineer cell lines, primary cells and difficult-to-transfect cells
  • Single animal component-free electroporation buffer for all cell types
  • Pre-loaded library of validated, cell specific protocols for plug-and-play transfection

 

Scalable

  • 5 x 106 to 7 x 108 cells in seconds
  • Up to 2 x 1010 cells in <30 minutes

 

Quality

  • Sterile, single use processing assemblies
  • Closed, cGMP-compliant, ISO-certified and CE-marked instruments
  • Supported by FDA master file

 

Scale up on the MaxCyte STX Requires No Re-optimization

 

CHO-S cells were transfected with an IgG expression plasmid via small- or large-scale electroporation using the MaxCyte STX. Antibody titers >1.2 grams/L were detected within two weeks of transient transfection for both transfections. A total of 3.4 grams of antibody was produced from a 2.8 L culture following a single transfection.

 

Resource Center

One Platform... Endless Applications

Read More

The MaxCyte STX has enabled us to meet our yearly protein production goal in five months!


Request Demo